Rx PRODUCTS
Committed to improving quality of life through cost-effective medications
CAMBER PHARMACEUTICALS
Leaders in Product Approvals & Launches
30
New Launches in 2024
45
ANDA Approvals this Year
29
New ANDAs Filed in 2024
One Vision. One Mission. One Camber.
Generic Rx, Specialty, OTC
Camber is made up of three groups with one common goal: to be the best generics company in the industry. Camber Pharmaceuticals is rapidly growing and had an industry leading 28 product approvals in 2022. With the support of our parent company, Hetero, we are poised to have a record number of product approvals and launches in 2023.
News and Events
October 29, 2024
Piscataway, NJ, October 29, 2024 – Camber Pharmaceuticals is excited to expand its product line with Avanafil […]
October 24, 2024
Although the DSCSA deadline has been extended, Camber has been ready for over a year. […]
October 10, 2024
Piscataway, NJ, October 10, 2024 – Camber Pharmaceuticals is pleased to announce the addition of […]
Camber Specialty Products
Camber Specialty will support the increasing demand for these products by providing hospitals, clinics, government facilities, and other institutional partners more high-quality generic choices.
Camber Consumer Care Over-the-Counter Products
We deliver high quality, over-the-counter medications you can trust. Our mission is to provide a focused and reliable supply of products to the marketplace, creating value for our partners and savings for the consumer.
Learn more
Vertical Advantage
Many of the generic medications Camber Pharmaceuticals offers in the United States are vertically integrated, from KSMs to APIs to FDFs. Camber products have consistent quality and reliable supply channels, helping reduce supply interruptions and mitigate risk.
Business Development
At Camber Pharmaceuticals, our goal is to bring affordable medicines to as many people as possible. As a company, we are continually interested in exploring business partnerships and licensing agreements with strategically aligned companies to support our diverse pipeline of generic products.
